HEADER    IMMUNOSUPPRESSANT                       24-FEB-92   1CYA              
TITLE     NMR STUDIES OF (U-13C)CYCLOSPORIN A BOUND TO CYCLOPHILIN: BOUND       
TITLE    2 CONFORMATION AND PORTIONS OF CYCLOSPORIN INVOLVED IN BINDING         
CAVEAT     1CYA    THE PUBLICATION DESCRIBES DETERMINATION OF CYCLOSPORIN A     
CAVEAT   2 1CYA    BOUND TO HUMAN CYCLOPHILIN. THE DEPOSITED ENTRY ONLY         
CAVEAT   3 1CYA    CONTAINS THE COORDINATES FOR THE CYCLOSPORIN ENTITY          
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: CYCLOSPORIN A;                                             
COMPND   3 CHAIN: A;                                                            
COMPND   4 SYNONYM: CYCLOSPORINE, CICLOSPORIN, CICLOSPORINE;                    
COMPND   5 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 SYNTHETIC: YES;                                                      
SOURCE   3 ORGANISM_SCIENTIFIC: TOLYPOCLADIUM INFLATUM;                         
SOURCE   4 ORGANISM_TAXID: 29910                                                
KEYWDS    IMMUNOSUPPRESSANT, CYCLOSPORIN A                                      
EXPDTA    SOLUTION NMR                                                          
MDLTYP    MINIMIZED AVERAGE                                                     
AUTHOR    S.W.FESIK                                                             
REVDAT   6   05-JUN-24 1CYA    1       LINK                                     
REVDAT   5   27-JUL-11 1CYA    1       HETATM REMARK                            
REVDAT   4   13-JUL-11 1CYA    1       VERSN                                    
REVDAT   3   24-FEB-09 1CYA    1       VERSN                                    
REVDAT   2   01-APR-03 1CYA    1       JRNL                                     
REVDAT   1   31-JAN-94 1CYA    0                                                
JRNL        AUTH   S.W.FESIK,R.T.GAMPE,H.L.EATON,G.GEMMECKER,E.T.OLEJNICZAK,    
JRNL        AUTH 2 P.NERI,T.F.HOLZMAN,D.A.EGAN,R.EDALJI                         
JRNL        TITL   NMR STUDIES OF [U-13C]CYCLOSPORIN A BOUND TO CYCLOPHILIN:    
JRNL        TITL 2 BOUND CONFORMATION AND PORTIONS OF CYCLOSPORIN INVOLVED IN   
JRNL        TITL 3 BINDING.                                                     
JRNL        REF    BIOCHEMISTRY                  V.  30  6574 1991              
JRNL        REFN                   ISSN 0006-2960                               
JRNL        PMID   2054356                                                      
JRNL        DOI    10.1021/BI00240A030                                          
REMARK   1                                                                      
REMARK   1 REFERENCE 1                                                          
REMARK   1  AUTH   S.W.FESIK,G.GEMMECKER,E.T.OLEJNICZAK,A.M.PETROS              
REMARK   1  TITL   IDENTIFICATION OF SOLVENT-EXPOSED REGIONS OF ENZYME-BOUND    
REMARK   1  TITL 2 LIGANDS BY NUCLEAR MAGNETIC RESONANCE                        
REMARK   1  REF    J.AM.CHEM.SOC.                V. 113  7080 1991              
REMARK   1  REFN                   ISSN 0002-7863                               
REMARK   1  DOI    10.1021/JA00018A080                                          
REMARK   1 REFERENCE 2                                                          
REMARK   1  AUTH   P.NERI,R.MEADOWS,G.GEMMECKER,E.OLEJNICZAK,D.NETTESHEIM,      
REMARK   1  AUTH 2 T.LOGAN,R.SIMMER,R.HELFRICH,T.HOLZMAN,J.SEVERIN,S.FESIK      
REMARK   1  TITL   1H, 13C AND 15N BACKBONE ASSIGNMENTS OF CYCLOPHILIN WHEN     
REMARK   1  TITL 2 BOUND TO CYCLOSPORIN A (CSA) AND PRELIMINARY STRUCTURAL      
REMARK   1  TITL 3 CHARACTERIZATION OF THE CSA BINDING SITE                     
REMARK   1  REF    FEBS LETT.                    V. 294    81 1991              
REMARK   1  REFN                   ISSN 0014-5793                               
REMARK   1  DOI    10.1016/0014-5793(91)81348-C                                 
REMARK   2                                                                      
REMARK   2 RESOLUTION. NOT APPLICABLE.                                          
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : X-PLOR                                               
REMARK   3   AUTHORS     : HARE RESEARCH INC. (DSPACE), BRUNGER (X-PLOR)        
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 1CYA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.                                
REMARK 100 THE DEPOSITION ID IS D_1000172593.                                   
REMARK 210                                                                      
REMARK 210 EXPERIMENTAL DETAILS                                                 
REMARK 210  EXPERIMENT TYPE                : NMR                                
REMARK 210  TEMPERATURE           (KELVIN) : NULL                               
REMARK 210  PH                             : NULL                               
REMARK 210  IONIC STRENGTH                 : NULL                               
REMARK 210  PRESSURE                       : NULL                               
REMARK 210  SAMPLE CONTENTS                : NULL                               
REMARK 210                                                                      
REMARK 210  NMR EXPERIMENTS CONDUCTED      : NULL                               
REMARK 210  SPECTROMETER FIELD STRENGTH    : NULL                               
REMARK 210  SPECTROMETER MODEL             : NULL                               
REMARK 210  SPECTROMETER MANUFACTURER      : NULL                               
REMARK 210                                                                      
REMARK 210  STRUCTURE DETERMINATION.                                            
REMARK 210   SOFTWARE USED                 : NULL                               
REMARK 210   METHOD USED                   : NULL                               
REMARK 210                                                                      
REMARK 210 CONFORMERS, NUMBER CALCULATED   : NULL                               
REMARK 210 CONFORMERS, NUMBER SUBMITTED    : 1                                  
REMARK 210 CONFORMERS, SELECTION CRITERIA  : NULL                               
REMARK 210                                                                      
REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL                
REMARK 210                                                                      
REMARK 210 REMARK: NULL                                                         
REMARK 215                                                                      
REMARK 215 NMR STUDY                                                            
REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION           
REMARK 215 NMR DATA.  PROTEIN DATA BANK CONVENTIONS REQUIRE THAT                
REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON              
REMARK 215 THESE RECORDS ARE MEANINGLESS.                                       
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 400                                                                      
REMARK 400 COMPOUND                                                             
REMARK 400 CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.                               
REMARK 400   HERE, CYCLOSPORIN A IS REPRESENTED BY THE SEQUENCE (SEQRES)        
REMARK 400                                                                      
REMARK 400 THE CYCLOSPORIN A IS CYCLIC PEPTIDE, A MEMBER OF IMMUNOSUPPRESSANT   
REMARK 400 CLASS.                                                               
REMARK 400                                                                      
REMARK 400  GROUP: 1                                                            
REMARK 400   NAME: CYCLOSPORIN A                                                
REMARK 400   CHAIN: A                                                           
REMARK 400   COMPONENT_1: PEPTIDE LIKE POLYMER                                  
REMARK 400   DESCRIPTION: CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION    
REMARK 400                IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI.     
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    ABA A   6       78.70   -116.16                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 1BCK   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN  
REMARK 900 C                                                                    
REMARK 900 RELATED ID: 1C5F   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF THE CYCLOPHILIN-LIKE DOMAIN FROM BRUGIA MALAYI  
REMARK 900 COMPLEXED WITH CYCLOSPORIN A                                         
REMARK 900 RELATED ID: 1CSA   RELATED DB: PDB                                   
REMARK 900 SOLUTION STRUCTURE OF E.COLI CYCLOPHILIN (F112W) COMPLEXED WITH      
REMARK 900 CYCLOSPORIN A                                                        
REMARK 900 RELATED ID: 1CWA   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN  
REMARK 900 A                                                                    
REMARK 900 RELATED ID: 1CWB   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED     
REMARK 900 CYCLOSPORIN A AT POSITION 5                                          
REMARK 900 RELATED ID: 1CWC   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED     
REMARK 900 CYCLOSPORIN A AT POSITION 8                                          
REMARK 900 RELATED ID: 1CWF   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN  
REMARK 900 D                                                                    
REMARK 900 RELATED ID: 1CWH   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN  
REMARK 900 A MODIFIED AT POSITION 7                                             
REMARK 900 RELATED ID: 1CWI   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED     
REMARK 900 CYCLOSPORIN D AT POSITION 7                                          
REMARK 900 RELATED ID: 1CWJ   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED     
REMARK 900 CYCLOSPORIN D AT POSITIONS 5 AND 7.                                  
REMARK 900 RELATED ID: 1CWK   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED     
REMARK 900 CYCLOSPORIN D AT POSITIONS 5 AND 7.                                  
REMARK 900 RELATED ID: 1CWL   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED     
REMARK 900 CYCLOSPORIN A AT POSITION 8                                          
REMARK 900 RELATED ID: 1CWM   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED     
REMARK 900 CYCLOSPORIN A AT POSITION 8                                          
REMARK 900 RELATED ID: 1CWO   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH NODIFIED     
REMARK 900 CYCLOSPORIN C AT POSITIONS 1, AND 9                                  
REMARK 900 RELATED ID: 1CYB   RELATED DB: PDB                                   
REMARK 900 SOLUTION STRUCTURE OF HUMAN CYCLOPHILIN COMPLEXED WITH CYCLOSPORIN A 
REMARK 900 RELATED ID: 1CYN   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN B COMPLEXED WITH MODIFIED     
REMARK 900 CYCLOSPORIN A                                                        
REMARK 900 RELATED ID: 1IKF   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF CTCLOSPORIN-FAB COMPLEX                         
REMARK 900 RELATED ID: 1M63   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF CALCINEURIN-CYCLOPHILIN-CYCLOSPORIN COMPLEX     
REMARK 900 RELATED ID: 1MF8   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CALCINEURIN COMPLEXED WITH HUMAN          
REMARK 900 CYCLOPHILIN AND CYCLOSPORIN A                                        
REMARK 900 RELATED ID: 1MIK   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED     
REMARK 900 CYCLOSPORIN A AT POSITION 6                                          
REMARK 900 RELATED ID: 1QNG   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM CYCLOPHILIN COMPLEXED     
REMARK 900 WITH CYCLOSPORIN A                                                   
REMARK 900 RELATED ID: 1QNH   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM CYCLOPHILIN (DOUBLE       
REMARK 900 MUTANT) COMPLEXED WITH CYCLOSPORIN A                                 
REMARK 900 RELATED ID: 1XQ7   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYCLOPHILIN COMPLEXED WITH    
REMARK 900 CYCLOSPORIN A                                                        
REMARK 900 RELATED ID: 2ESL   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN C COMPLEXED WITH CYCLOSPORIN  
REMARK 900 A                                                                    
REMARK 900 RELATED ID: 2OJU   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN J COMPLEXED WITH CYCLOSPORIN  
REMARK 900 A                                                                    
REMARK 900 RELATED ID: 2POY   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF CRYPTOSPORIDIUM PARVUM IOWA II CYCLOPHILIN A    
REMARK 900 COMPLEXED WITH CYCLOSPORIN A                                         
REMARK 900 RELATED ID: 2RMA   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN  
REMARK 900 A                                                                    
REMARK 900 RELATED ID: 2RMB   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED     
REMARK 900 CYCLOSPORIN A AT POSITION 5                                          
REMARK 900 RELATED ID: 2RMC   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF MURINE CYCLOPHILIN C COMPLEXED WITH             
REMARK 900 CYCLOSPORIN A                                                        
REMARK 900 RELATED ID: 2WFJ   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF THE PPIASE DOMAIN OF HUMAN CYCLOPHILIN G        
REMARK 900 COMPLEXED WITH CYCLOSPORIN A                                         
REMARK 900 RELATED ID: 2X2C   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN ACETYL-CYPA COMPLEXED WITH CYCLOSPORINE A 
REMARK 900 RELATED ID: 2X7K   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF PPIL1 COMPLEXED WITH CYCLOSPORINE A             
REMARK 900 RELATED ID: 2Z6W   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN D IN COMPLEX WITH             
REMARK 900 CYCLOSPORIN A                                                        
REMARK 900 RELATED ID: 3BO7   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF CYCLOSPHILIN A FROM TOXOPLASMA GONDII           
REMARK 900 COMPLEXED WIT CYCLOSPORIN A                                          
REMARK 900 RELATED ID: 3CYS   RELATED DB: PDB                                   
REMARK 900 SOLUTION STRUCTURE OF THE HUMAN CYCLOSPORIN A COMPLEXED WITH         
REMARK 900 CYCLOSPORIN A                                                        
REMARK 900 RELATED ID: 3EOV   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF CYCLOPHILIN FROM LEISHMANIA DONOVANI COMPLEXED  
REMARK 900 WITH CYCLOSPORIN A                                                   
DBREF  1CYA A    1    11  NOR    NOR00033 NOR00033         1     11             
SEQRES   1 A   11  DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA                  
HET    DAL  A   1      10                                                       
HET    MLE  A   2      22                                                       
HET    MLE  A   3      22                                                       
HET    MVA  A   4      19                                                       
HET    BMT  A   5      30                                                       
HET    ABA  A   6      13                                                       
HET    SAR  A   7      10                                                       
HET    MLE  A   8      22                                                       
HET    MLE  A  10      22                                                       
HETNAM     DAL D-ALANINE                                                        
HETNAM     MLE N-METHYLLEUCINE                                                  
HETNAM     MVA N-METHYLVALINE                                                   
HETNAM     BMT 4-METHYL-4-[(E)-2-BUTENYL]-4,N-METHYL-THREONINE                  
HETNAM     ABA ALPHA-AMINOBUTYRIC ACID                                          
HETNAM     SAR SARCOSINE                                                        
FORMUL   1  DAL    C3 H7 N O2                                                   
FORMUL   1  MLE    4(C7 H15 N O2)                                               
FORMUL   1  MVA    C6 H13 N O2                                                  
FORMUL   1  BMT    C10 H19 N O3                                                 
FORMUL   1  ABA    C4 H9 N O2                                                   
FORMUL   1  SAR    C3 H7 N O2                                                   
LINK         C   DAL A   1                 N   MLE A   2     1555   1555  1.32  
LINK         N   DAL A   1                 C   ALA A  11     1555   1555  1.31  
LINK         C   MLE A   2                 N   MLE A   3     1555   1555  1.32  
LINK         C   MLE A   3                 N   MVA A   4     1555   1555  1.32  
LINK         C   MVA A   4                 N   BMT A   5     1555   1555  1.34  
LINK         C   BMT A   5                 N   ABA A   6     1555   1555  1.31  
LINK         C   ABA A   6                 N   SAR A   7     1555   1555  1.32  
LINK         C   SAR A   7                 N   MLE A   8     1555   1555  1.32  
LINK         C   MLE A   8                 N   VAL A   9     1555   1555  1.31  
LINK         C   VAL A   9                 N   MLE A  10     1555   1555  1.32  
LINK         C   MLE A  10                 N   ALA A  11     1555   1555  1.31  
CRYST1    1.000    1.000    1.000  90.00  90.00  90.00 P 1           1          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      1.000000  0.000000  0.000000        0.00000                         
SCALE2      0.000000  1.000000  0.000000        0.00000                         
SCALE3      0.000000  0.000000  1.000000        0.00000                         
HETATM    1  N   DAL A   1      -3.475  -5.796  -2.483  1.00  0.00           N  
HETATM    2  CA  DAL A   1      -2.306  -6.025  -3.402  1.00  0.00           C  
HETATM    3  CB  DAL A   1      -2.629  -7.241  -4.253  1.00  0.00           C  
HETATM    4  C   DAL A   1      -1.081  -6.271  -2.507  1.00  0.00           C  
HETATM    5  O   DAL A   1      -1.268  -6.515  -1.331  1.00  0.00           O  
HETATM    6  H   DAL A   1      -3.851  -6.548  -1.980  1.00  0.00           H  
HETATM    7  HA  DAL A   1      -2.143  -5.180  -4.047  1.00  0.00           H  
HETATM    8  HB1 DAL A   1      -2.723  -8.097  -3.609  1.00  0.00           H  
HETATM    9  HB2 DAL A   1      -1.899  -7.467  -5.003  1.00  0.00           H  
HETATM   10  HB3 DAL A   1      -3.553  -7.047  -4.767  1.00  0.00           H  
HETATM   11  N   MLE A   2       0.129  -6.214  -3.025  1.00  0.00           N  
HETATM   12  CN  MLE A   2       0.472  -5.872  -4.466  1.00  0.00           C  
HETATM   13  CA  MLE A   2       1.320  -6.460  -2.112  1.00  0.00           C  
HETATM   14  CB  MLE A   2       2.113  -7.681  -2.609  1.00  0.00           C  
HETATM   15  CG  MLE A   2       1.186  -8.895  -2.842  1.00  0.00           C  
HETATM   16  CD1 MLE A   2       2.033 -10.015  -3.442  1.00  0.00           C  
HETATM   17  CD2 MLE A   2       0.605  -9.402  -1.515  1.00  0.00           C  
HETATM   18  C   MLE A   2       2.192  -5.217  -2.182  1.00  0.00           C  
HETATM   19  O   MLE A   2       3.235  -5.286  -2.801  1.00  0.00           O  
HETATM   20  HN1 MLE A   2       1.516  -5.700  -4.607  1.00  0.00           H  
HETATM   21  HN2 MLE A   2      -0.026  -4.979  -4.805  1.00  0.00           H  
HETATM   22  HN3 MLE A   2       0.227  -6.688  -5.112  1.00  0.00           H  
HETATM   23  HA  MLE A   2       1.059  -6.596  -1.077  1.00  0.00           H  
HETATM   24  HB2 MLE A   2       2.849  -7.944  -1.863  1.00  0.00           H  
HETATM   25  HB3 MLE A   2       2.634  -7.449  -3.525  1.00  0.00           H  
HETATM   26  HG  MLE A   2       0.379  -8.653  -3.520  1.00  0.00           H  
HETATM   27 HD11 MLE A   2       2.464  -9.691  -4.378  1.00  0.00           H  
HETATM   28 HD12 MLE A   2       2.829 -10.279  -2.762  1.00  0.00           H  
HETATM   29 HD13 MLE A   2       1.420 -10.886  -3.621  1.00  0.00           H  
HETATM   30 HD21 MLE A   2      -0.021  -8.660  -1.045  1.00  0.00           H  
HETATM   31 HD22 MLE A   2       0.002 -10.278  -1.703  1.00  0.00           H  
HETATM   32 HD23 MLE A   2       1.405  -9.670  -0.841  1.00  0.00           H  
HETATM   33  N   MLE A   3       1.790  -4.117  -1.574  1.00  0.00           N  
HETATM   34  CN  MLE A   3       0.439  -3.831  -0.959  1.00  0.00           C  
HETATM   35  CA  MLE A   3       2.656  -2.859  -1.659  1.00  0.00           C  
HETATM   36  CB  MLE A   3       1.791  -1.722  -2.336  1.00  0.00           C  
HETATM   37  CG  MLE A   3       1.380  -2.224  -3.724  1.00  0.00           C  
HETATM   38  CD1 MLE A   3       0.188  -1.422  -4.211  1.00  0.00           C  
HETATM   39  CD2 MLE A   3       2.580  -2.084  -4.695  1.00  0.00           C  
HETATM   40  C   MLE A   3       3.209  -2.357  -0.358  1.00  0.00           C  
HETATM   41  O   MLE A   3       2.838  -2.830   0.698  1.00  0.00           O  
HETATM   42  HN1 MLE A   3      -0.208  -3.453  -1.738  1.00  0.00           H  
HETATM   43  HN2 MLE A   3       0.543  -3.098  -0.172  1.00  0.00           H  
HETATM   44  HN3 MLE A   3      -0.025  -4.685  -0.519  1.00  0.00           H  
HETATM   45  HA  MLE A   3       3.537  -3.046  -2.240  1.00  0.00           H  
HETATM   46  HB2 MLE A   3       2.264  -0.771  -2.458  1.00  0.00           H  
HETATM   47  HB3 MLE A   3       0.945  -1.427  -1.735  1.00  0.00           H  
HETATM   48  HG  MLE A   3       1.080  -3.255  -3.690  1.00  0.00           H  
HETATM   49 HD11 MLE A   3      -0.612  -1.573  -3.497  1.00  0.00           H  
HETATM   50 HD12 MLE A   3       0.438  -0.376  -4.249  1.00  0.00           H  
HETATM   51 HD13 MLE A   3      -0.127  -1.781  -5.176  1.00  0.00           H  
HETATM   52 HD21 MLE A   3       3.404  -2.746  -4.481  1.00  0.00           H  
HETATM   53 HD22 MLE A   3       2.248  -2.333  -5.682  1.00  0.00           H  
HETATM   54 HD23 MLE A   3       2.956  -1.073  -4.668  1.00  0.00           H  
HETATM   55  N   MVA A   4       4.103  -1.390  -0.465  1.00  0.00           N  
HETATM   56  CN  MVA A   4       4.970  -0.954  -1.659  1.00  0.00           C  
HETATM   57  CA  MVA A   4       4.683  -0.841   0.826  1.00  0.00           C  
HETATM   58  CB  MVA A   4       6.199  -1.216   0.929  1.00  0.00           C  
HETATM   59  CG1 MVA A   4       6.738  -0.808   2.318  1.00  0.00           C  
HETATM   60  CG2 MVA A   4       6.326  -2.751   0.872  1.00  0.00           C  
HETATM   61  C   MVA A   4       4.507   0.698   0.855  1.00  0.00           C  
HETATM   62  O   MVA A   4       5.520   1.365   0.795  1.00  0.00           O  
HETATM   63  HN1 MVA A   4       5.295   0.065  -1.543  1.00  0.00           H  
HETATM   64  HN2 MVA A   4       5.819  -1.605  -1.761  1.00  0.00           H  
HETATM   65  HN3 MVA A   4       4.496  -0.991  -2.626  1.00  0.00           H  
HETATM   66  HA  MVA A   4       4.233  -1.248   1.724  1.00  0.00           H  
HETATM   67  HB  MVA A   4       6.807  -0.740   0.175  1.00  0.00           H  
HETATM   68 HG11 MVA A   4       7.778  -1.090   2.392  1.00  0.00           H  
HETATM   69 HG12 MVA A   4       6.662   0.250   2.503  1.00  0.00           H  
HETATM   70 HG13 MVA A   4       6.187  -1.328   3.089  1.00  0.00           H  
HETATM   71 HG21 MVA A   4       5.804  -3.188   1.711  1.00  0.00           H  
HETATM   72 HG22 MVA A   4       5.907  -3.162  -0.032  1.00  0.00           H  
HETATM   73 HG23 MVA A   4       7.368  -3.031   0.931  1.00  0.00           H  
HETATM   74  N   BMT A   5       3.305   1.278   0.936  1.00  0.00           N  
HETATM   75  CN  BMT A   5       2.094   0.372   0.750  1.00  0.00           C  
HETATM   76  CA  BMT A   5       3.335   2.808   0.958  1.00  0.00           C  
HETATM   77  C   BMT A   5       3.380   3.278   2.416  1.00  0.00           C  
HETATM   78  O   BMT A   5       3.436   2.472   3.324  1.00  0.00           O  
HETATM   79  CB  BMT A   5       2.080   3.494   0.319  1.00  0.00           C  
HETATM   80  OG1 BMT A   5       0.946   3.159   1.107  1.00  0.00           O  
HETATM   81  CG2 BMT A   5       1.791   3.038  -1.138  1.00  0.00           C  
HETATM   82  CD1 BMT A   5       3.078   3.163  -1.967  1.00  0.00           C  
HETATM   83  CD2 BMT A   5       0.661   3.873  -1.786  1.00  0.00           C  
HETATM   84  CE  BMT A   5       0.987   5.370  -1.763  1.00  0.00           C  
HETATM   85  CZ  BMT A   5       0.075   6.295  -1.293  1.00  0.00           C  
HETATM   86  CH  BMT A   5       0.387   7.791  -1.258  1.00  0.00           C  
HETATM   87  HN1 BMT A   5       2.079  -0.421   1.484  1.00  0.00           H  
HETATM   88  HN2 BMT A   5       1.158   0.882   0.822  1.00  0.00           H  
HETATM   89  HN3 BMT A   5       2.103  -0.038  -0.240  1.00  0.00           H  
HETATM   90  HA  BMT A   5       4.185   3.229   0.433  1.00  0.00           H  
HETATM   91  HB  BMT A   5       2.260   4.562   0.350  1.00  0.00           H  
HETATM   92  HG1 BMT A   5       0.575   3.973   1.454  1.00  0.00           H  
HETATM   93  HG2 BMT A   5       1.476   2.013  -1.181  1.00  0.00           H  
HETATM   94 HD11 BMT A   5       3.593   4.081  -1.730  1.00  0.00           H  
HETATM   95 HD12 BMT A   5       3.733   2.332  -1.745  1.00  0.00           H  
HETATM   96 HD13 BMT A   5       2.846   3.145  -3.022  1.00  0.00           H  
HETATM   97 HD22 BMT A   5      -0.263   3.706  -1.251  1.00  0.00           H  
HETATM   98 HD23 BMT A   5       0.526   3.565  -2.812  1.00  0.00           H  
HETATM   99  HE  BMT A   5       1.948   5.710  -2.119  1.00  0.00           H  
HETATM  100  HZ  BMT A   5      -0.885   5.950  -0.938  1.00  0.00           H  
HETATM  101  HH1 BMT A   5       0.947   8.015  -0.362  1.00  0.00           H  
HETATM  102  HH2 BMT A   5       0.968   8.054  -2.129  1.00  0.00           H  
HETATM  103  HH3 BMT A   5      -0.540   8.346  -1.255  1.00  0.00           H  
HETATM  104  N   ABA A   6       3.358   4.572   2.612  1.00  0.00           N  
HETATM  105  CA  ABA A   6       3.405   5.167   3.995  1.00  0.00           C  
HETATM  106  C   ABA A   6       2.127   5.949   4.357  1.00  0.00           C  
HETATM  107  O   ABA A   6       2.136   7.163   4.295  1.00  0.00           O  
HETATM  108  CB  ABA A   6       4.604   6.107   4.072  1.00  0.00           C  
HETATM  109  CG  ABA A   6       5.875   5.301   3.793  1.00  0.00           C  
HETATM  110  H   ABA A   6       3.309   5.170   1.837  1.00  0.00           H  
HETATM  111  HA  ABA A   6       3.583   4.403   4.739  1.00  0.00           H  
HETATM  112  HB3 ABA A   6       4.660   6.549   5.056  1.00  0.00           H  
HETATM  113  HB2 ABA A   6       4.501   6.894   3.339  1.00  0.00           H  
HETATM  114  HG1 ABA A   6       5.811   4.839   2.819  1.00  0.00           H  
HETATM  115  HG3 ABA A   6       6.737   5.950   3.819  1.00  0.00           H  
HETATM  116  HG2 ABA A   6       5.994   4.530   4.540  1.00  0.00           H  
HETATM  117  N   SAR A   7       1.051   5.287   4.726  1.00  0.00           N  
HETATM  118  CA  SAR A   7      -0.206   6.045   5.082  1.00  0.00           C  
HETATM  119  C   SAR A   7      -1.464   5.367   4.518  1.00  0.00           C  
HETATM  120  O   SAR A   7      -2.278   4.900   5.290  1.00  0.00           O  
HETATM  121  CN  SAR A   7       1.084   3.856   5.180  1.00  0.00           C  
HETATM  122  HA2 SAR A   7      -0.182   7.061   4.706  1.00  0.00           H  
HETATM  123  HA3 SAR A   7      -0.291   6.079   6.159  1.00  0.00           H  
HETATM  124  HN1 SAR A   7       0.100   3.495   5.444  1.00  0.00           H  
HETATM  125  HN2 SAR A   7       1.733   3.777   6.040  1.00  0.00           H  
HETATM  126  HN3 SAR A   7       1.478   3.247   4.380  1.00  0.00           H  
HETATM  127  N   MLE A   8      -1.628   5.308   3.215  1.00  0.00           N  
HETATM  128  CN  MLE A   8      -0.722   5.876   2.157  1.00  0.00           C  
HETATM  129  CA  MLE A   8      -2.862   4.641   2.639  1.00  0.00           C  
HETATM  130  CB  MLE A   8      -3.581   5.564   1.602  1.00  0.00           C  
HETATM  131  CG  MLE A   8      -4.251   6.864   2.230  1.00  0.00           C  
HETATM  132  CD1 MLE A   8      -5.739   6.606   2.507  1.00  0.00           C  
HETATM  133  CD2 MLE A   8      -3.643   7.262   3.575  1.00  0.00           C  
HETATM  134  C   MLE A   8      -2.426   3.360   1.920  1.00  0.00           C  
HETATM  135  O   MLE A   8      -2.083   3.388   0.754  1.00  0.00           O  
HETATM  136  HN1 MLE A   8       0.282   5.963   2.526  1.00  0.00           H  
HETATM  137  HN2 MLE A   8      -1.072   6.853   1.857  1.00  0.00           H  
HETATM  138  HN3 MLE A   8      -0.718   5.234   1.290  1.00  0.00           H  
HETATM  139  HA  MLE A   8      -3.570   4.352   3.405  1.00  0.00           H  
HETATM  140  HB2 MLE A   8      -4.328   4.951   1.114  1.00  0.00           H  
HETATM  141  HB3 MLE A   8      -2.925   5.875   0.805  1.00  0.00           H  
HETATM  142  HG  MLE A   8      -4.149   7.727   1.582  1.00  0.00           H  
HETATM  143 HD11 MLE A   8      -6.248   6.358   1.587  1.00  0.00           H  
HETATM  144 HD12 MLE A   8      -6.194   7.489   2.933  1.00  0.00           H  
HETATM  145 HD13 MLE A   8      -5.848   5.786   3.201  1.00  0.00           H  
HETATM  146 HD21 MLE A   8      -4.148   8.152   3.920  1.00  0.00           H  
HETATM  147 HD22 MLE A   8      -2.594   7.492   3.503  1.00  0.00           H  
HETATM  148 HD23 MLE A   8      -3.802   6.493   4.312  1.00  0.00           H